A phase 1 trial of NeoVax with nivolumab in platinum-sensitive ovarian cancer found the personalised vaccine feasible with an acceptable safety profile.
Trending
- Saturn’s 274 Moons: The Largest Moon Family in the Solar System
- NeoVax and Nivolumab: Inside the Ovarian Cancer Vaccine Trial
- Starlink in Ukraine: Musk Points to Washington as Access Questions Grow
- AI Data Center Spending Is Outpacing Revenue — and the Math Is Getting Uncomfortable
- Microsoft Documents Warned Its AI Could Start a ‘Doom Loop’ That Guts the Web
- AI Data Centers Are Getting So Expensive the Math No Longer Adds Up
- Improving Readability on Small Screens
- How Dental Practices Can Build Ethical Billing Workflows
